1 – 10 of 2160
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Recombinant factor IX Fc for the treatment of hemophilia B
2024) In European Journal of Haematology(
- Contribution to journal › Scientific review
-
Mark
Genome-wide CRISPR/Cas9 screen identifies regulators of BCMA expression on multiple myeloma cells
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Ontogeny shapes the ability of ETV6::RUNX1 to enhance hematopoietic stem cell self-renewal and disrupt early lymphopoiesis
2024) In Leukemia(
- Contribution to journal › Letter
-
Mark
Evidence that CD36 is expressed on red blood cells and constitutes a novel blood group system of clinical importance
(
- Contribution to journal › Article
-
Mark
Red blood cell-derived arginase release in hemolytic uremic syndrome
(
- Contribution to journal › Article
-
Mark
LIN28B promotes differentiation of fully transformed AML cells but is dispensable for fetal leukemia suppression
2024) In Leukemia(
- Contribution to journal › Letter
- 2023
-
Mark
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma : The Swedish MCL complete Project
(
- Contribution to journal › Article
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
2023) In Haematologica(
- Contribution to journal › Article
-
Mark
PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
(
- Contribution to journal › Article
-
Mark
Truncated glycosyltransferase coding regions in novel ABO alleles give rise to weak A or B blood group expression and discrepant typing results
(
- Contribution to journal › Article